Delaying the start of iron until 28 days after antimalarial treatment is associated with lower incidence of subsequent illness in children with malaria and iron deficiency

PLoS ONE

Volumn 12, Issue 8, 2017, Pages

  Jaramillo, Ericka G ^a   Mupere, Ezekiel ^b   Opoka, Robert O ^b   Hodges, James S ^c   Lund, Troy C ^d   Georgieff, Michael K ^d   John, Chandy C ^e   Cusick, Sarah E ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UPR   (United States)

^e INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; FERROUS SULFATE; PROTOPORPHYRIN ZINC; ANTIMALARIAL AGENT; IRON;

ARTICLE; BLOOD SMEAR; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL EXAMINATION; MORBIDITY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SECONDARY ANALYSIS; THERAPY DELAY; UGANDAN; ANEMIA, IRON-DEFICIENCY; COMPLICATION; PRESCHOOL CHILD; UGANDA;

ANEMIA, IRON-DEFICIENCY; ANTIMALARIALS; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; IRON; MALARIA; MALE; UGANDA;

EID: 85028680714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0183977     Document Type: Article

References (18)

1. Conclusions and recommendations of the WHO Consultation on prevention and control of iron deficiency in infants and young children in malaria-endemic areas. Food Nutr Bull. 2007; 28(4 Suppl); S621–7. PMID: 18297899
2. World Health Organziation e-library of Evidence for Nutrition Actions. Accessed at: http://www.who.int/elena/titles/guidance_summaries/micronutrientpowder_infants/en/.
3. Desai MR, Dhar R, Rosen DH, Kariuki SK, Shi YP, Kager PA, Ter Kuile FO. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyramethamine for the treatment of mild childhood anemia in western Kenya. J Infect Dis. 2003; 187(4):658–66. https://doi.org/10.1086/367986 PMID: 12599083
4. Nwanyanwu OC, Ziba C, Kazembe PN, Gamadzi G, Gandwe J, Redd SC. The effect of oral iron therapy during treatment for Plasmodium falciparum malaria with sulphadoxine-pyramethamine on Malawian children under 5 years of age. Ann Trop Med Parasitol. Dec 1996; 90(6):589–595. PMID: 9039270
5. Verhoef H, West CE, Nzyuko SM, de Vogel S, van der Valk R, Wanga MA, Kuijsten A, Veenemans J, Kok FJ. Intermittent administration of iron and sulfadoxine-pyramethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet. 2002; 360(9337):908–14. https://doi.org/10.1016/ S0140-6736(02)11027-0 PMID: 12354473
6. Howard CT, McKakpo US, Quakyi IA, Bosompem KM, Addison EA, Sun K, Sullivan D, Semba RD. Relationship of hepcidin with parasitemia and anemia among patients with uncomplicated malaria in Ghana. Am J Trop Med Hyg. 2007 77(4):623–6. PMID: 17978060
7. de Mast Q, Nadjm B, Reyburn H, Kemna EH, Amos B, Lassrakkers CM, Silalye S, Verhoef H, Sauerwein RW, Swinkels D. Assessment of Urinary Concentrations of Hepcidin Provides Novel Insight into Disturbances in Iron Homeostasis during Malarial Infection. 2009. J Infect Dis; 199 (2): 253–262. https://doi.org/10.1086/595790 PMID: 19032104
8. Cusick SE, Opoka RO, Abrams SA, John CC, Georgieff MK, Mupere E. Delaying Iron Therapy until 28 Days after Antimalarial Treatment Is Associated with Greater Iron Incorporation and Equivalent Hematologic Recovery after 56 Days in Children: A Randomized Controlled Trial. J Nutr. 2016; 146(9):1769–74. https://doi.org/10.3945/jn.116.233239 PMID: 27358418
9. Clark M, Morgan MG, Fulford A. Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum. Nature Communications. 2014. 5, Article number: 4446.
10. World Health Organization. Management of Severe Malaria: A Practical Handbook. 3rd ed. 2012. Accessed at: http://apps.who.int/iris/bitstream/10665/79317/1/9789241548526_eng.pdf.
11. Ojukwu JU, Okebe JU, Yahav D, Paul M. (2009). Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas. Cochrane Database Syst Rev, 2009 (3).
12. Okebe JU, Yahav D, Shbita R, Paul M. (2011). Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst Rev, 2011 (10).
13. Neuberger A, Okebe J, Yahav D, Paul M. (2016) Oral iron supplements for children in malaria-endemic areas. Cochrane Database of Syst Rev, 2016(2).
14. Soofi S, Cousens S, Iqbal SP, Akhund T, Khan J, Ahmed I, Zaidi AK, Bhutta ZA. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomized trial. Lancet. 2013 Jul 6; 382 (9886):29–40. https://doi.org/10.1016/S0140-6736(13)60437-7 PMID: 23602230
15. Zimmermann MB, Chassard C, Rohner F, N’goran EK, Nindjin C, Dostal A, Utzinger J, Ghattas H, Lacroix C, Hurrell RF. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d’Ivoire. Am J Clin Nutr. 2010 Dec; 92(6):1406–15. https://doi.org/10.3945/ajcn.110.004564 PMID: 20962160
16. Jaeggi T, Kortman GA, Moretti D, Chassard C, Holding P, Dostal A, Boekhorst J, Timmerman HM, Swinkels DW, Tjalsma H, Njenga J, Mwangi A, Kvalsvig J, Lacroix C, Zimmermann MB. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015 May; 64(5);731–42. https://doi.org/10.1136/gutjnl-2014-307720 PMID: 25143342
17. Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJ, de Boer JD, Hoogendijk AJ, de Beer R, de Vos A, Belzer C, de Vos WM, van der Poll T, Wiersinga WJ. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016 Apr; 65(4):575–83. https://doi.org/10.1136/gutjnl-2015-309728 Epub 2015 Oct 28. PMID: 26511795
18. Marsland Benjamin J., Trompette Aurélien, and Gollwitzer Eva S.. The Gut—Lung Axis in Respiratory Disease. Annals of the American Thoracic Society, Vol. 12, No. Supplement 2(2015), pp. S150–S156.